Published in Gut on August 01, 2004
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis (2009) 3.40
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med (2013) 2.30
Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. Gastroenterology (2010) 1.93
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry. Gastrointest Endosc (2015) 1.45
Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? World J Surg (2015) 1.45
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology (2012) 1.28
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res (2008) 1.15
The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma. Mol Cancer (2010) 1.03
Endoscopic evaluation of esophago-gastro-jejunostomy in rat model of Barrett's esophagus. Dis Esophagus (2009) 1.00
Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study. World J Gastroenterol (2005) 0.98
Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol (2008) 0.95
Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study. Clin Gastroenterol Hepatol (2013) 0.95
Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer (2014) 0.95
Development and maintenance of cancer stem cells under chronic inflammation. J Nippon Med Sch (2011) 0.95
Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma. Clin Cancer Res (2011) 0.94
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma. PLoS One (2011) 0.94
The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma. Br J Cancer (2012) 0.93
The changing face of esophageal cancer. Cancers (Basel) (2010) 0.92
Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network. Br J Cancer (2008) 0.91
Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc (2012) 0.88
Color-matched and fluorescence-labeled esophagus phantom and its applications. J Biomed Opt (2013) 0.87
Inflammation to cancer: The molecular biology in the pancreas (Review). Oncol Lett (2014) 0.86
Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model. Int J Cancer (2009) 0.85
Epidermal growth factor receptor expression in esophageal adenocarcinoma: relationship with tumor stage and survival after esophagectomy. Gastroenterol Res Pract (2012) 0.84
The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma. Surg Endosc (2008) 0.84
Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure? Langenbecks Arch Surg (2008) 0.83
Clinical puzzle: Barrett's oesophagus. Dis Model Mech (2008) 0.82
Endoscopic therapy for Barrett's oesophagus. Gut (2005) 0.82
In vivo cancer biomarkers of esophageal neoplasia. Cancer Biomark (2008) 0.82
Global changes in gene expression of Barrett's esophagus compared to normal squamous esophagus and gastric cardia tissues. PLoS One (2014) 0.80
NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study. BMJ Open (2015) 0.80
Management strategies of Barrett's esophagus. World J Gastroenterol (2012) 0.79
Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry. Dis Esophagus (2015) 0.79
Meta-analysis of Barrett's esophagus in China. World J Gastroenterol (2013) 0.79
The changing profile of esophageal cancer presentation and its implication for diagnosis. J Natl Med Assoc (2007) 0.79
Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine? World J Gastroenterol (2011) 0.78
Tongue-like Barrett's esophagus is associated with gastroesophageal reflux disease. World J Gastroenterol (2008) 0.78
Negative impact of sedation on esophagogastric junction evaluation during esophagogastroduodenoscopy. World J Gastroenterol (2014) 0.77
Label-free multi-photon imaging of dysplasia in Barrett's esophagus. Biomed Opt Express (2015) 0.77
Association Between Alcohol Consumption and the Risk of Barrett's Esophagus: A Meta-Analysis of Observational Studies. Medicine (Baltimore) (2015) 0.77
Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort. Gastrointest Endosc (2016) 0.77
Polymorphisms of MTHFR and susceptibility to oesophageal adenocarcinoma in a Caucasian United Kingdom population. World J Gastroenterol (2014) 0.76
Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol (2016) 0.76
Barrett's Esophagus: A Review of Biology and Therapeutic Approaches. Gastrointest Cancer Res (2012) 0.76
Oesophageal cancer and gastro-oesophageal reflux: what is the relationship? Gut (2004) 0.76
Undervalued criteria in the evaluation of multimodal trials for upper GI cancers. Cancer Invest (2014) 0.75
The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort. United European Gastroenterol J (2016) 0.75
Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink. Cancer Epidemiol (2016) 0.75
Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Low grade dysplasia in Barrett's esophagus: Should we worry? World J Gastrointest Pathophysiol (2014) 0.75
The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future. BMJ Case Rep (2009) 0.75
Clonal evolution of colorectal cancer in IBD. Nat Rev Gastroenterol Hepatol (2017) 0.75
The epidemiology, diagnosis, and treatment of Barrett's carcinoma. Dtsch Arztebl Int (2015) 0.75
Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and Survival. Gastroenterol Res Pract (2015) 0.75
The Prevalence of Barrett Esophagus Diagnosed in the Second Endoscopy: A Retrospective, Observational Study at a Tertiary Center. Medicine (Baltimore) (2016) 0.75
Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther (2016) 0.75
Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol. BMJ Open (2016) 0.75
Inhibition of pRB Pathway Differentially Modulates Apoptosis in Esophageal Cancer Cells. Transl Oncol (2017) 0.75
A feasibility study of photoacoustic imaging of ex vivo endoscopic mucosal resection tissues from Barrett's esophagus patients. Endosc Int Open (2017) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
The UK General Practice Research Database. Lancet (1997) 10.62
Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology (2000) 4.74
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med (1985) 4.30
Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23
Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology (1984) 3.36
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97
Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut (1996) 2.75
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut (1991) 2.29
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol (1999) 2.26
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf (2002) 2.12
Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med (1991) 2.01
Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg (1996) 1.99
Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut (1992) 1.96
Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med (2001) 1.91
Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg (1988) 1.91
Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut (1989) 1.88
Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer (1997) 1.84
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ (2003) 1.61
Heartburn--a serious symptom. N Engl J Med (1999) 1.58
Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer (1993) 1.57
Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol (1999) 1.55
The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol (1998) 1.35
Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut (2001) 1.34
Barrett's oesophagus: a clinical study of 52 patients. Q J Med (1987) 1.28
The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol (1988) 1.24
Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol (1997) 1.12
Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992. Int J Epidemiol (1996) 1.10
Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg (1996) 1.10
Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol (1998) 1.07
Adenocarcinoma arising in Barrett's esophagus. Dig Dis Sci (1989) 1.06
Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland. Br J Cancer (2000) 1.06
Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg (1993) 0.88
Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Eur J Gastroenterol Hepatol (1997) 0.87
Barrett's oesophagus. Eur J Cancer Prev (1992) 0.87
Changing pattern of oesophageal cancer incidence in France. Int J Epidemiol (1994) 0.82
The significance of heartburn. QJM (2000) 0.79
Molecular analysis of FRIGIDA, a major determinant of natural variation in Arabidopsis flowering time. Science (2000) 9.08
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart (2007) 5.36
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Influences on control in diabetes mellitus: patient, doctor, practice, or delivery of care? BMJ (1993) 3.45
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Recent advances in coeliac disease. Gut (2006) 3.20
Physical map and organization of Arabidopsis thaliana chromosome 4. Science (1995) 3.05
Do single handed practices offer poorer care? Cross sectional survey of processes and outcomes. BMJ (2001) 2.97
The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax (2011) 2.76
An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods (1990) 2.72
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax (2006) 2.59
Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy (2012) 2.58
Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. J Immunol (1987) 2.53
Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell (2001) 2.45
A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol (1989) 2.33
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ (2008) 2.32
B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol (1995) 2.29
Home safety education and provision of safety equipment for injury prevention. Cochrane Database Syst Rev (2007) 2.18
Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis (1995) 2.10
Anomalous insertion of the medial meniscus of the knee. A case report. J Bone Joint Surg Am (1995) 2.06
Further improvements on the phosphotriester synthesis of deoxyribooligonucleotides and the oligonucleotide directed site-specific mutagenesis of E. coli lipoprotein gene. Nucleic Acids Res (1983) 2.05
Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc Natl Acad Sci U S A (2001) 2.05
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial. Ann Intern Med (1999) 2.01
Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res (2000) 1.99
Rapid magnetic resonance quantification on the brain: Optimization for clinical usage. Magn Reson Med (2008) 1.73
Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax (2005) 1.71
Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A (2000) 1.69
Description of 31 YAC contigs spanning the majority of Arabidopsis thaliana chromosome 5. Plant J (1997) 1.59
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer (2006) 1.58
Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent. Eur J Immunol (1989) 1.57
Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann Surg (1991) 1.57
Antibiotic use and the development of Crohn's disease. Gut (2004) 1.56
Screening for visual impairment in elderly patients with hip fracture: validating a simple bedside test. Eye (Lond) (2005) 1.53
Validation of a home safety questionnaire used in a randomised controlled trial. Inj Prev (2003) 1.52
Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ (2001) 1.51
Current opinion on treatment of asymptomatic retinal detachments. Eye (Lond) (2006) 1.50
Does routine child health surveillance reach children most at risk of accidental injury? J Public Health Med (1995) 1.49
Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol (2004) 1.42
Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol (2003) 1.42
Implantable, polymeric systems for modulated drug delivery. Adv Drug Deliv Rev (2002) 1.42
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart (2005) 1.41
Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J (1982) 1.39
Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet (1997) 1.39
Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis. Heart (2005) 1.37
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther (2002) 1.35
Active parental consent in school-based research. An examination of ethical and methodological issues. Eval Rev (1996) 1.34
Fracture experience of patients with coeliac disease: a population based survey. Gut (2003) 1.30
5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut (2005) 1.29
Tubulin is phosphorylated at tyrosine by pp60c-src in nerve growth cone membranes. J Cell Biol (1990) 1.28
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther (2005) 1.27
Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg (1999) 1.25
Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD. Br J Cancer (2010) 1.24
Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther (2004) 1.24
Recall of informed consent information by healthy volunteers in clinical trials. QJM (2008) 1.24
Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet (2000) 1.22
Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol Ther (2004) 1.22
Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. J Mol Biol (2001) 1.19
Circulatory response to systemic infusion of norepinephrine in the pregnant ewe. Am J Obstet Gynecol (1977) 1.18
Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev (2002) 1.18
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut (2004) 1.17
Patient perceptions of the burden of coeliac disease and its treatment in the UK. Aliment Pharmacol Ther (2009) 1.16
Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer (2001) 1.15
Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax (2006) 1.15
Detailed description of four YAC contigs representing 17 Mb of chromosome 4 of Arabidopsis thaliana ecotype Columbia. Plant J (1996) 1.15
Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort) Study Group. Calcif Tissue Int (1996) 1.13
Delayed light studies on photosynthetic energy conversion. II. Effect of electron acceptors and phosphorylation cofactors on the millisecond emission from chloroplasts. Biochim Biophys Acta (1969) 1.13
Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology (2005) 1.11
Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle. Mol Pharmacol (1992) 1.09
Differential patterns of executive function in children with attention-deficit hyperactivity disorder according to gender and subtype. J Child Neurol (1999) 1.09
Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified? Aliment Pharmacol Ther (2004) 1.09
Smoking cessation treatment in primary care: prospective cohort study. Tob Control (2005) 1.08
National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding. Br J Surg (2012) 1.08
Letter: the burden of co-morbidity in the population contributes more to upper gastrointestinal bleeding than aspirin. Aliment Pharmacol Ther (2013) 1.07
Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther (2014) 1.07
Recent studies on the zoopharmacognosy, pharmacology and neurotoxicology of sesquiterpene lactones. Planta Med (1995) 1.06
Mortality from acute upper gastrointestinal bleeding in the United kingdom: does it display a "weekend effect"? Am J Gastroenterol (2011) 1.06
Incisional wound healing: a controlled study of low and high dose ultrasound. J Orthop Sports Phys Ther (1993) 1.05
Potential role for phosphatidic acid in mediating the inflammatory responses to TNF alpha and IL-1 beta. Circ Shock (1994) 1.05
The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther (2010) 1.05
Fertility rates in women with asthma, eczema, and hay fever: a general population-based cohort study. Am J Epidemiol (2007) 1.05
Circulatory patterns in the normal hand. Br J Surg (1973) 1.05
Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis (2000) 1.04
Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.03
Solution structure of a highly stable DNA duplex conjugated to a minor groove binder. Nucleic Acids Res (1998) 1.03
A 10 year prospective followup of patients with rheumatoid arthritis 1986-96. J Rheumatol (2001) 1.03
The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer (2008) 1.03
Characterization of three Agrobacterium tumefaciens avirulent mutants with chromosomal mutations that affect induction of vir genes. J Bacteriol (1991) 1.02
Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay. Microb Pathog (1999) 1.02